- Filed
- Feb 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 18, 2025 | 120.06M sh |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $435.5M |
| Short Term Debt | FY 2024 · Dec 31, 2023 | $244K |
| Short Term Investments | FY 2024 · Dec 31, 2023 | $35.59M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $258.42M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | −$35.68M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $79.35M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $217.05M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $462.15M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $935.08M |
| Current Assets | FY 2024 · Dec 31, 2023 | $481.08M |
| Total Assets | FY 2024 · Dec 31, 2023 | $899.39M |
| Shares Diluted restated | FY 2024 · Dec 31, 2022 | 97.35M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $1.81M |
| Capex | FY 2024 · Dec 31, 2022 | $2.35M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$17.74M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$1.61 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$1.61 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $109.81M |
| Net Income | FY 2024 · Dec 31, 2022 | −$156.56M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$177.05M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $107.58M |
| Revenue | FY 2024 · Dec 31, 2022 | $275.95M |